STAGE IB LUNG CANCER AJCC V8
Clinical trials for STAGE IB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug stop lung cancer before it starts?
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab could prevent lung cancer from coming back in 45 people with early-stage lung cancer or high-risk lung nodules. Participants received the drug and were monitored for tumor response and survival. The goal was to see if…
Matched conditions: STAGE IB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 15, 2026 18:57 UTC
-
Lung cancer vaccine shows promise in early prevention trial
Prevention CompletedThis early-phase study tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein that can fuel cancer growth. Researchers checked for side effects and m…
Matched conditions: STAGE IB LUNG CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated Jun 10, 2026 13:27 UTC
-
Heart monitors reveal hidden risks after cancer radiation
Knowledge-focused CompletedThis study looked at heart changes in 24 people receiving radiation or chemo-radiation for lung or esophageal cancer that hadn't spread. Participants got a small heart monitor implanted to track heart problems that might otherwise go unnoticed. The goal was to better understand a…
Matched conditions: STAGE IB LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 17, 2026 00:41 UTC